Siolta Therapeutics
Latest round
- Series C
Last raised
- Mar 2024
Total raised
- $42M
Investors
- 6
About Siolta Therapeutics
Based in California, US, and founded in 2016 by CEO Nikole Kimes, Siolta Therapeutics, Inc. operates as a developer of microbiome therapeutics combined with bacteria, fungi, protozoa, and viruses that lives inside the human body to treat and prevent inflammatory diseases. In March 2024, Siolta Therapeutics, Inc. Siolta Therapeutics, Inc. developed live biotherapeutics and molecular diagnostic tools to target the core drivers of diseases particularly within the maternal-infant axis. It leverages advanced microbial science, clinical data, and bioinformatics to create targeted therapies. The company’s products are designed to reestablish a healthy gut microbiome using naturally occurring bacteria and are focused to prevent and treat a variety of diseases, including atopic conditions and other disorders associated with microbiome dysbiosis.
Who invested in Siolta Therapeutics
6 investors across 2 rounds
See all investors in Siolta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Siolta Therapeutics
Who invested in Siolta Therapeutics?
Siolta Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Siolta Therapeutics raised?
Siolta Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Siolta Therapeutics last raise money?
Siolta Therapeutics's most recent round on record is a Series C, in Mar 2024.
What does Siolta Therapeutics do?
Based in California, US, and founded in 2016 by CEO Nikole Kimes, Siolta Therapeutics, Inc.
Where is Siolta Therapeutics headquartered?
Siolta Therapeutics is headquartered in San Carlos, US.
Which VCs invest in companies like Siolta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Siolta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Siolta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.